141x Filetype PDF File size 0.46 MB Source: pdfs.semanticscholar.org
pharmaceutics Review EvidenceofDrug–NutrientInteractionswith ChronicUseofCommonlyPrescribed Medications: AnUpdate EmilyS.Mohn1,HuaJ.Kern2,EdwardSaltzman1,SusanH.Mitmesser2andDianeL.McKay1,* 1 Jean MayerUSDAHumanNutritionResearchCenteronAging, andFriedmanSchoolofNutritionScienceandPolicy,TuftsUniversity,Boston,MA02111,USA; emily.mohn@tufts.edu (E.S.M.); edward.saltzman@tufts.edu (E.S.) 2 Nutrition & Scientific Affairs, Nature’s Bounty Co., Ronkonkoma, NY 11779, USA; carinakern@nbty.com (H.J.K.); susanmitmesser@nbty.com (S.H.M.) * Correspondence: diane.mckay@tufts.edu; Tel.: +1-781-608-7183 Received: 13 February 2018; Accepted: 16 March 2018; Published: 20 March 2018 Abstract: The long-term use of prescription and over-the-counter drugs can induce subclinical and clinically relevant micronutrient deficiencies, which may develop gradually over months or even years. Giventhelargenumberofmedicationscurrentlyavailable,thenumberofresearchstudiesexamining potential drug–nutrient interactions is quite limited. A comprehensive, updated review of the potential drug–nutrient interactions with chronic use of the most often prescribed medications for commonly diagnosed conditions among the general U.S. adult population is presented. For the majority of the interactionsdescribedinthispaper,morehigh-qualityinterventiontrialsareneededtobetterunderstand their clinical importanceandpotentialconsequences. Anumberofthesestudieshaveidentifiedpotential risk factors that may make certain populations more susceptible, but guidelines on how to best manage and/orpreventdrug-inducednutrientinadequaciesarelacking. Althoughwidespreadsupplementation is not currently recommended, it is important to ensure at-risk patients reach their recommended intakes for vitamins and minerals. In conjunction with an overall healthy diet, appropriate dietary supplementationmaybeapracticalandefficaciouswaytomaintainorimprovemicronutrientstatusin patients at risk of deficiencies, such as those taking medications known to compromise nutritional status. Thesummaryevidencepresentedinthisreviewwillhelpinformfutureresearcheffortsand,ultimately, guiderecommendationsforpatientcare. Keywords:drug–nutrientinteraction;micronutrientdeficiencies;nutrientinadequacies;multivitamin; dietary supplement 1. Introduction Thelong-termuseofprescriptionandoverthecounter(OTC)drugscaninducesubclinicaland clinically relevant micronutrient deficiencies which may develop gradually over months or even years. Unfortunately, nutrient deficiencies seldom present as classically described and, with the exception of the most commonmicronutrientissues, manyhealthcareprovidersarenotknowledgeableabout micronutrient deficiency or excess. This may lead to erroneous attribution of deficiency states to adiseasestate or the aging process itself [1] and may delay diagnosis. Drug-induced micronutrient depletion may be the origin of otherwise unexplained symptoms, some of which might influence medication compliance [2]. Drug–nutrientinteractions are defined as physical, chemical, physiologic, or pathophysiologic relationships between a drug and a nutrient, and typically involve multiple factors [3,4]. Drugs can influencefoodintake,nutrientdigestion,absorption,distribution,metabolismtoactiveforms,function, Pharmaceutics 2018, 10, 36; doi:10.3390/pharmaceutics10010036 www.mdpi.com/journal/pharmaceutics Pharmaceutics 2018, 10, 36 2of45 catabolism and excretion [5,6]. Additionally, the presence of compound-specific transport proteins, receptors, and enzymes in different tissues alters the pattern and location of where drugs and nutrients interact, creating scores of possible tissue-specific interactions [4,5], and makes prediction of clinical effects difficult. Ethanol and tobacco also influence micronutrients in ways similar to drugs, but discussion of this is beyond the scope of this review. AccordingtotheNationalAmbulatoryCareServiceSurveyreleasedbytheNationalCenterfor HealthStatistics, the chronic conditions most often present in patients >45 years that require chronic drug use include hypertension, hyperlipidemia, arthritis, diabetes, depression, asthma, ischemic heart disease, and chronic obstructive pulmonary disease (COPD) [7]. Data from the National Health Interview Survey showed the prevalence of hypertension among adults was 29.0% in 2011–2014 and increased with age [8]. Furthermore 12% of individuals aged 45–64 years, and 29.4% aged ≥65 years were diagnosed with heart disease (all types), 27.4% of all adults aged ≥20 years had hypercholesteremia, and 11.9% had diabetes. Although only 3.4% of adults were reported to have serious psychological distress, including depression, these adults were more likely to have COPD, heart disease, and diabetes [9]. This suggests there is a higher prevalence of depression in individuals withchronicdisease. A substantial number of adults reported having conditions that may warrant the use of nonsteroidal anti-inflammatory drugs (NSAIDS) or corticosteroids, including osteoarthritis, which is the most common cause of disability in older adults, as well as low back pain (28.1% of adults), severe headache or migraine (15.3%), and neck pain (14.6%). The overall prevalence of asthma amongadultsis7.6%,butthisrateincreasedwithobesity(11.1%),particularly among women(14.6%). In addition, a considerable number of women (26.7%) aged <45 years reported the regular use of oral contraceptives. Given the large number of medications currently available, the number of research studies examiningpotentialdrug–nutrientinteractionsisquitelimited. APubmedsearchrevealedthenumber of published research studies describing the potential effects of drug–drug interactions exceeds those describing drug–nutrient interactions by 100 fold. Often the resources on drug–nutrient interactions that are readily available to health care providers simply repeat the same lists of outdated or obscure examples, and seldom provide any perspective on the degree or quality of the supporting evidence. Acomprehensive,updatedreviewofthepotentialdrug–nutrientinteractionswithuseofthemostoften prescribed medications for commonly diagnosed conditions among the general U.S. adult population is warranted. Thus, the goal of this review is to update the available evidence as it relates to these conditions, and enhance awareness of the potential nutrition-related problems with chronic use of commonlyprescribedmedications(Table1). Pharmaceutics 2018, 10, 36 3of45 Table1. Summaryofpotentialdrug–nutrientinteractions and knownriskfactors. DrugCategory Name Nutrient Effect on Nutrient HumanStudies1 RiskFactors References Status or Function Advancedage 5observational H.pylori infection 5intervention Genetics (slow metabolizers Decrease 1observation Lowdietaryintake(vegetarians) [10–17] VitaminB12 Decrease 4intervention H.pylori infection [18–22] VitaminC Decrease 2casereports Pre-existing iron deficiency [23] Acid-Suppressing Drugs Proton PumpInhibitors Iron Decrease 1observational Vegetarians [24–28] CalciumMagnesium Decrease 2intervention Advancedage [29–31] Zinc Decrease >10observational Women – β-Carotene Decrease 4intervention Advancedage – 30 case reports Durationofdruguse 2intervention Women 1intervention Undetermined Undetermined 1observational Absenceofcoldvirus Non-Steroidal Aspirin VitaminC Decrease 4intervention Advancedage [32–35] Anti-InflammatoryDrugs Iron Decrease 6observational H.pylori infection [36–39] 8intervention Dose/durationofdruguse Formofloopdiuretic Advancedage Women Advancedage Heartfailure LowMgintake Alcohol use >20observational Long-termuse 9intervention Coronaryheartfailure >10observational Advancedage 1intervention Lowdietarythiaminintake Decrease (loop) 4observational Hepatic cirrhosis [40–48] Calcium Increase (thiazide) 2intervention Diabetes mellitus loop Magnesium Decrease (loop and 3observational Heartfailure [42,49–54] Thiamin thiazide) 6intervention Gastro-intestinal disorders thiazide Diuretics (loop, thiazide) Zinc Decrease (loop) 3observational Renaldisease [55–57] Diuretics Potassium Decrease (thiazide) >100intervention Lowdietaryzincintake [58–62] Anti-Hypertensives (potassium-sparing) Folate Decrease (thiazide) 2casereports Dose [63–69] Angiotensin-Converting Zinc Decrease 1observational Formofthiazideused [70–74] EnzymeInhibitors Potassium Decrease 3observational Lowfolatestatus [75,76] CalciumChannelBlockers Iron 2 Increase 6intervention Impairedliver function [77–85] Folate N/A 2casereports Liver cirrhosis (alcoholics) [86–91] Potassium Decrease 3observational Useofcaptopril – Increase 1intervention Heartfailure [92–99] 1intervention Renaldisease [100–103] 6casereports Age(elderly) 3observational Renaldisease 2casereports Diabetes mellitus 2observational Congestive heart failure Potassiumsupplementuse Undetermined Presence of dental plaque Poororalhygiene Gender(men) Dose Lowfolateintakes Concurrentuseofbeta-blockers Pharmaceutics 2018, 10, 36 4of45 Table1. Cont. DrugCategory Name Nutrient Effect on Nutrient HumanStudies1 RiskFactors References Status or Function 7observational Dose CoenzymeQ10 >10intervention Advancedage VitaminD Decrease >10observational Statin-associated myopathy [104–114] Hypercholesterolemics Statins Vitamin Increase/Decrease 4intervention Heartdisease [115–128] E/β-Carotene Increase/Decrease 1observational VitaminDdeficiency – 6intervention Statin-associated myopathy Undetermined Dose/durationofdruguse >10observational Advancedage Hypoglycemics Biguanides (Metformin) VitaminB12 Decrease >10intervention Vegetarians [129–140] Thiazolidinediones Calcium/VitaminD Decrease 3observational Advancedage [141–145] >10intervention Women Lowcalcium/vitaminDintake >80observational Calcium/VitaminD Decrease >10intervention Lowcalcium/vitaminDintake [146–154] Corticosteroids Glucocorticoids (oral) Sodium/Potassium Increase (sodium) ~5case Atriskforbonefracture/loss – Chromium Decrease (potassium) reports/observational Undetermined – Decrease 1intervention Undetermined 1intervention >10observational Presence of COPDSmoking Bronchodilators Corticosteroids (inhaled) Calcium/VitaminD Decrease >10intervention Atriskforbonefracture/loss [155–159] Lowcalcium/vitaminDintake Lowfolateintake Selective Serotonin Folate 3 Increase 3 5observational Genetics (MTHFRvariants) [160–167] Antidepressants ReuptakeInhibitors Calcium/VitaminD Decrease 2intervention Alcoholism [168–171] >10observational Atriskforbonefracture/loss Lowcalcium/vitaminDintake Undetermined >10observational Vegetarians 5intervention Lowfolateintake VitaminB6 Decrease 4casereports Genetics (folate) – VitaminB12/Folate Decrease >30observational Durationofdruguse [172–183] Oral Contraceptives Estrogen and/or Calcium Increase/decrease 5intervention Durationofdruguse [184–193] Progesterone Magnesium Decrease 7observational Physical activity level [194–200] VitaminC/VitaminE Decrease 6intervention Lowcalciumintake – >20observational Ageatfirstuse >10observational Race 2intervention TypeofcombinedOCused Undetermined 1 Total number of studies that have investigated the potential drug–nutrient interaction (includes both significant and null results); 2 Nutrient effect on drug side effect; 3 Effect of nutrient ondrugefficacy.
no reviews yet
Please Login to review.